Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer (EPICAP-QALY)

November 18, 2025 updated by: Centre Hospitalier Universitaire de Nīmes
To study the quality of life of patients with prostate cancer at a distance from their care at a time when they are supposed to have taken a "normal" life and compared to subjects without cancer prostate of the same age.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

900

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 75 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Target population: incident cases of prostate cancer

Description

- exposed group

Inclusion Criteria:

  • prostate cancer diagnosed from 1 December 2011 to 31 December 2014
  • under 75 and residing in the Hérault department at diagnosis
  • recruited in the EPICAP study

Exclusion criteria:

  • having relapsed in the range
  • non-exposed group:

Inclusion Criteria:

  • controls (without prostate cancer) recruited in the EPICAP study
  • matched to cases on age (5 years)
  • residing in the Hérault department

Exclusion criteria:

  • diagnosis of prostate cancer set in the range

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Prostate Cancer
Group drawn of the case group of the case control study, entitled EPICAP
Procedure: therapeutic management of the prostate Cancer as usual
No Prostate Cancer
Group drawn of the control group of the case control study, entitled EPICAP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
EORTC Quality of Life Questionnaire - Core 30 Score (EORTC QLQ-C30 Score)
Time Frame: 3 years from diagnosis for cases of prostate cancer and from recruitment for controls
3 years from diagnosis for cases of prostate cancer and from recruitment for controls

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Universitaire de Nīmes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2015

Primary Completion (Actual)

July 31, 2017

Study Completion (Actual)

July 31, 2017

Study Registration Dates

First Submitted

August 1, 2016

First Submitted That Met QC Criteria

August 1, 2016

First Posted (Estimated)

August 4, 2016

Study Record Updates

Last Update Posted (Estimated)

November 21, 2025

Last Update Submitted That Met QC Criteria

November 18, 2025

Last Verified

August 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LIGUE/2014/NH-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on therapeutic management of the prostate Cancer as usual

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe